New pill shows promise for rare lymphoma – no chemo needed yet
NCT ID NCT07441993
First seen Apr 24, 2026 · Last updated Apr 30, 2026 · Updated 2 times
Summary
This study tests a drug called orelabrutinib in people with marginal zone lymphoma who have not had any prior treatment. The goal is to see if the drug can shrink or control the cancer. About 30 adults will take the pill and be monitored for side effects and how well the cancer responds.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MARGINAL ZONE LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Nantong University
RECRUITINGNantong, Jiangsu, China
-
Beijing Tongren Hospital, Capital Medical University
RECRUITINGBeijing, China
-
Hematology Hospital, Chinese Academy of Medical Sciences
RECRUITINGTianjin, China
-
Henan Cancer Hospital
RECRUITINGZhengzhou, Henan, China
-
Jiangsu Province People's Hospital
RECRUITINGNanjing, Jiangsu, China
-
Nanfang Hospital, Southern Medical University
RECRUITINGGuangzhou, Guangdong, China
-
Qilu Hospital of Shandong University
RECRUITINGJinan, Shandong, China
-
Shandong Cancer Hospital & Institute
RECRUITINGJinan, Shandong, China
-
Shandong Provincial Hospital
RECRUITINGJinan, Shandong, China
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, China
-
The First Bethune Hospital of Jilin University
RECRUITINGChangchun, Jilin, China
-
The Second Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, China
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, China
-
Xiangyang Central Hospital
RECRUITINGXiangyang, Hubei, China
Conditions
Explore the condition pages connected to this study.